Stay updated on Pembrolizumab for T/NK-cell Lymphomas Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab for T/NK-cell Lymphomas Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab for T/NK-cell Lymphomas Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Adds the investigator’s name and new navigation headings, and removes older phrasing and revision notes, reflecting updates to the page’s metadata and user guidance.
    Difference
    2%
    Check dated 2026-06-12T12:46:44.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    Revision tag updated to v3.5.5, replacing v3.5.4. This signals a new page version without changes to the study content.
    Difference
    0.1%
    Check dated 2026-06-05T08:25:43.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    No Change Detected
  5. Check
    33 days ago
    Change Detected
    Summary
    The page shows a new revision number in the footer (v3.5.4) compared with the previous version. The overall study details and content on the page remain the same.
    Difference
    0.1%
    Check dated 2026-05-15T05:48:48.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    The page footer revision number was updated from v3.5.2 to v3.5.3, indicating a non-content site/version change.
    Difference
    0.1%
    Check dated 2026-04-24T05:47:56.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T02:21:02.000Z thumbnail image
  8. Check
    91 days ago
    Change Detected
    Summary
    Revision metadata updated to v3.5.0. The previous revision v3.4.3 was removed from the history.
    Difference
    0.1%
    Check dated 2026-03-18T21:03:58.000Z thumbnail image

Stay in the know with updates to Pembrolizumab for T/NK-cell Lymphomas Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for T/NK-cell Lymphomas Clinical Trial page.